Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II

References

• Lopez A, Mathers C, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1714–1717 (2006).
   Google Scholar
• Das UN. Hypertension as a low‑grade systemic inflammatory condition that has its origins in the perinatal period. J. Assoc. Physicians India 54, 133–142 (2006).
   Google Scholar
• Luc G, Bard J‑M, Juhan‑Vague I et al. C‑reactive protein, interleukins‑6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler. Thromb. Vasc. Biol. 23, 1255–1261 (2003).
   Google Scholar
• Das UN. Is obesity an inflammatory condition? Nutrition 17, 953–966 (2001). ▪▪ One of the first reports to suggest that obesity could be a low-grade systemic inflammatory condition.
   Google Scholar
• Das UN. Is metabolic syndrome X an inflammatory condition? Exp. Biol. Med. (Maywood) 227, 989–997 (2002).
   Google Scholar
• Ridker PM, Burning JE, Cook NR, Rifai N. C‑reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 107, 391–397 (2003).
   Google Scholar
• Das UN. Is metabolic syndrome X a disorder of the brain with the initiation of lowgrade systemic inflammatory events during the perinatal period? J. Nutr. Biochem. 18, 701–713 (2007).
   Google Scholar
• Das UN. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer’s disease – but how and why? Prostaglandins Leukot. Essent. Fatty Acids 78, 11–19 (2008).
   Google Scholar
• Das UN. Is depression a low‑grade systemic inflammatory condition? Am. J. Clin. Nutr. 85, 1665–1666 (2007).
   Google Scholar
• Dougan M, Dranoff G. Inciting inflammation: the RAGE about tumor promotion. J. Exp. Med. 205, 267–270 (2008).
   Google Scholar
• Visser M, Bouter LM, McQuillan GM et al. Elevated C‑reactive protein levels in overweight and obese adults. JAMA 282, 2131–2135 (1999).
   Google Scholar
• Hotamisligil GS. The role of TNF‑alpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245, 621–625 (1999).
   Google Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C‑reactive protein, interleukin‑6, and risk of developing Type 2 diabetes mellitus. JAMA 286, 327–334 (2001).
   Google Scholar
• Das UN. GLUT‑4, tumor necrosis factor, essential fatty acids and daf‑genes and their role in glucose homeostasis, insulin resistance, non‑insulin dependent diabetes mellitus and longevity. J. Assoc. Physicians India 47, 431–435 (1999).
   Google Scholar
• Fichtlscherer S, Rosenberger G, Walter DH et al. Elevated C‑reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102, 1000–1006 (2000).
   Google Scholar
• Cleland SJ, Sattar N, Petrie JR et al. Endothelial dysfunction as a possible link between C‑reactive protein levels and cardiovascular disease. Clin. Sci. (Colch.) 98, 531–535 (2000).
   Google Scholar
• Das UN. Non‑alcoholic fatty liver disease as a pro‑resolution defective disorder. Nutrition 29, 345–349 (2013). One of the first suggestions that nonalcoholic fatty liver disease is a low-grade systemic inflammatory condition.
   Google Scholar
• Das UN. Lipoxins, resolvins, protectins, maresins, and nitrolipids: connecting lipids, inflammation, and cardiovascular disease risk. Curr. Cardio. Risk Rep. 4, 24–31 (2010). Suggests possible roles for lipoxins (LXs), resolvins (Rvs) and protectins in cardiovascular diseases.
   Google Scholar
• Das UN. Cross talk among leukocytes, platelets, and endothelial cells and its relevance to atherosclerosis and coronary heart disease. Current Nutr. Food Sci. 5, 75–93 (2009).
   Google Scholar
• Das UN. Is multiple sclerosis a proresolution deficiency disorder? Nutrition 28, 951–958 (2012).
   Google Scholar
• Popp J, Bacher M, Kölsch H et al. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease. J. Psychiatr. Res. 43, 749–753 (2009).
   Google Scholar
• Patel NS, Paris D, Mathura V, Quadros AN, Crawford FC, Mullan MJ. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer’s disease. J. Neuroinflammation 2, 9 (2005).
   Google Scholar
• Wei H, Zou H, Sheikh AM et al. IL‑6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J. Neuroinflammation 8, 52 (2011).
   Google Scholar
• Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part I. Clin. Lipidol. 8(4), 437–463 (2013). Reviews available evidence that suggests that LXs, Rvs and protectins could have a role in cancer.
   Google Scholar
• Nassar GM, Morrow JD, Roberts LJ 2nd, Lakkis FG, Badr KF. Induction of 15‑lipoxygenase by interleukin‑13 in human blood monocytes. J. Biol. Chem. 269, 27631–27634 (1994).
   Google Scholar
• Nassar GM, Montero A, Fukunaga M, Badr KF. Contrasting effects of proinflammatory and T‑helper lymphocyte subset‑2 cytokines on the 5‑lipoxygenase pathway in monocytes. Kidney Int. 51, 1520–1528 (1997).
   Google Scholar
• Profita M, Sala A, Siena L et al. Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin‑4‑induced 15‑lipoxygenase. J. Pharmacol. Exp. Ther. 300, 868–875 (2002).
   Google Scholar
• Denizot Y, Raher S, Trimoreau F, Praloran V, Godard A. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. Cytokine 12, 499–502 (2000).
   Google Scholar
• Katoh T, Lakkis FG, Makita N, Badr KF. Co‑regulated expression of glomerular 12/15‑lipoxygenase and interleukin‑4 mRNAs in rat nephrotoxic nephritis. Kidney Int. 46, 341–349 (1994).
   Google Scholar
• Nassar GM, Badr KF. Role of leukotrienes and lipoxygenases in glomerular injury. Miner. Electrolyte Metab. 21, 262–270 (1995).
   Google Scholar
• Papayianni A, Serhan CN, Phillips ML, Rennke HG, Brady HR. Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int. 47, 1295–1302 (1995). Original study that showed that LX may have a role in glomerulonephritis.
   Google Scholar
• O’Meara YM, Brady HR. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Kidney Int. Suppl. 58, S56–S61 (1997).
   Google Scholar
• Wu SH, Liao PY, Yin PL, Zhang YM, Dong L. Elevated expressions of 15‑lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am. J. Pathol. 174, 115–122 (2009).
   Google Scholar
• Lattin JE, Schroder K, Su AI et al. Expression analysis of G protein‑coupled receptors in mouse macrophages. Immunome Res. 4, 5 (2008).
   Google Scholar
• Milligan G, Stoddart LA, Brown AJ. G protein‑coupled receptors for free fatty acids. Cell. Signal. 18, 1360–1365 (2006).
   Google Scholar
• Oh DY, Talukdar S, Bae EJ et al. GPR120 is an omega‑3 fatty acid receptor mediating potent anti‑inflammatory and insulinsensitizing effects. Cell 142, 687–698 (2010).
   Google Scholar
• Das UN. Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J. Inflammation Res. 3, 143–170 (2010).
   Google Scholar
• Das UN. Is there a role for saturated and long‑chain fatty acids in multiple sclerosis? Nutrition 19, 163–166 (2003).
   Google Scholar
• Das UN. Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis. 10, 76 (2011).
   Google Scholar
• Hwang PL. Unsaturated fatty acids as endogenous inhibitors of tamoxifen binding to anti‑oestrogen‑binding sites. Biochem. J. 237, 749–755 (1986).
   Google Scholar
• Hwang PL. Interaction of unsaturated fatty acids with anti‑oestrogen‑binding sites. Biochem. J. 243, 359–364 (1987).
   Google Scholar
• Russell R, Gori I, Pellegrini C, Kumar R, Achtari C, Canny GO. Lipoxin A4 is a novel estrogen receptor modulator. FASEB J. 25, 4326–4337 (2011). Interesting study that showed that LX modulates and mediates the action of the estrogen receptor.
   Google Scholar
• Sodin‑Semrl S, Taddeo B, Tseng D, Varga J, Fiore S. Lipoxin A4 inhibits IL‑1 betainduced IL‑6, IL‑8, and matrix metalloproteinase‑3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164, 2660–2666 (2000).
   Google Scholar
• He R, Sang H, Ye RD. Serum amyloid A induces IL‑8 secretion through a G proteincoupled receptor, FPRL1/LXA4R. Blood 101, 1572–1581 (2003).
   Google Scholar
• Filep JG, Khreiss T, József L. Lipoxins and aspirin‑triggered lipoxins in neutrophil adhesion and signal transduction. Prostaglandins Leukot. Essent. Fatty Acids 73, 257–262 (2005).
   Google Scholar
• Menezes‑de‑Lima O Jr, Kassuya CA, Nascimento AF, Henriques Md, Calixto JB. Lipoxin A4 inhibits acute edema in mice: implications for the anti‑edematogenic mechanism induced by aspirin. Prostaglandins Other Lipid Mediat. 80, 123–135 (2006).
   Google Scholar
• Baker N, O’Meara SJ, Scannell M, Maderna P, Godson C. Lipoxin A4: anti‑inflammatory and anti‑angiogenic impact on endothelial cells. J. Immunol. 182, 3819–3826 (2009).
   Google Scholar
• Decker Y, McBean G, Godson C. Lipoxin A4 inhibits IL‑1beta‑induced IL‑8 and ICAM‑1 expression in 1321N1 human astrocytoma cells. Am. J. Physiol. Cell Physiol. 296, C1420–C1427 (2009).
   Google Scholar
• El Kebir D, József L, Pan W et al. 15‑epi‑lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 180, 311–319 (2009). Interesting study that showed that LX inhibits myeloperoxidase production from neutrophils and augments resolution of injury.
   Google Scholar
• Simões RL, Niconi‑de‑Almeida Y, da‑Fé AR, Barja‑Fidalgo C, Fierro IM. A synthetic analog of 15‑epi‑lipoxin A4 inhibits human monocyte apoptosis: involvement of ERK‑2 and PI3‑kinase. Prostaglandins Other Lipid Mediat. 91, 10–17 (2010).
   Google Scholar
• Prieto P, Cuenca J, Través PG, Fernández‑Velasco M, Martín‑Sanz P, Boscá L. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf‑2 defense pathways. Cell Death Differ. 17, 1179–1188 (2010).
   Google Scholar
• Paul‑Clark MJ, Van Cao T, Moradi‑Bidhendi N, Cooper D, Gilroy DW. 15‑epi‑lipoxin A4‑mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200, 69–78 (2004).
   Google Scholar
• de Wilde J, Smit E, Mohren R et al. An 8‑week high‑fat diet induces obesity and insulin resistance with small changes in the muscle transcriptome of C57BL/6J mice. J. Nutrigenet. Nutrigenomics 2, 280–291 (2009).
   Google Scholar
• Pagel‑Langenickel I, Bao J, Pang L, Sack MN. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr. Rev. 31, 25–51 (2010).
   Google Scholar
• Das UN. Exercise and inflammation. Eur. Heart J. 27, 1385–1386 (2006).
   Google Scholar
• Das UN. Anti‑inflammatory nature of exercise. Nutrition 20, 323–326 (2004).
   Google Scholar
• Teixeira de Lemos E, Reis F, Baptista S, Pinto R et al. Exercise training decreases proinflammatory profile in Zucker diabetic (Type 2) fatty rats. Nutrition 25, 330–339 (2009).
   Google Scholar
• Yamashita N, Hoshida S, Otsu K et al. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J. Exp. Med. 189, 1699–1706 (1999).
   Google Scholar
• Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C‑reactive protein and the calculated Framingham coronary heart disease risk score. Circulation 108, 161–165 (2003).
   Google Scholar
• van der Meer IM, de Maat MP, Hak AE et al. C‑reactive protein predicts progression of atherosclerosis measured as various sites in the arterial tree. The Rotterdam Study. Stroke 33, 2750–2755 (2002).
   Google Scholar
• Barzilay JI, Abraham L, Heckbert SR et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 50, 2384–2389 (2001).
   Google Scholar
• Das UN. A Perinatal Strategy for Preventing Adult Diseases: the Role of Long-chain Polyunsaturated Fatty Acids. Kluwer Academic Publishers, MA, USA (2002). Original proposal that perinatal supplementation of unsaturated fatty acids prevents obesity, diabetes mellitus (DM) and hypertension, among others.
   Google Scholar
• Das UN. Metabolic Syndrome Pathophysiology: the Role of Essential Fatty Acids Fatty Acids and their metabolites. Wiley‑Blackwell Publishers, IA, USA, (2010). Comprehensive review of the role of polyunsaturated fatty acids (PUFAs) and their products such as LXs, Rvs and protectins in the pathophysiology of metabolic syndrome.
   Google Scholar
• Das UN. Obesity: genes, brain, gut and environment. Nutrition 26, 559–473 (2010).
   Google Scholar
• Das UN. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21, 762–773 (2005).
   Google Scholar
• Dixit VD. Adipose‑immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J. Leukoc. Biol. 84, 882–892 (2008).
   Google Scholar
• Badawi A, Klip A, Haddad P et al. Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention. Diabetes Metab. Syndr. Obes. 3, 173–186 (2010).
   Google Scholar
• Peeters AC, Netea MG, Janssen MC, Kullberg BJ, Van der Meer JW, Thien T. Proinflammatory cytokines in patients with essential hypertension. Eur. J. Clin. Invest. 31, 31–36 (2001).
   Google Scholar
• Das UN. Arachidonic acid and lipoxin A4 as possible endogenous anti‑diabetic molecules. Prostaglandins Leukot. Essent. Fatty Acids 88, 201–210 (2013).
   Google Scholar
• Börgeson E, McGillicuddy FC, Harford KA et al. Lipoxin A4 attenuates adipose inflammation. FASEB J. 26, 4287–4294 (2012). Original study in which it was shown that lipoxin arrested adipose tissue inflammation.
   Google Scholar
• Titos E, Rius B, González‑Périz A et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2‑like phenotype. J. Immunol. 187, 5408–5418 (2011). Original study that showed that docosahexaenoic acid and its antiinflammatory product RvD1 attenuated adipose tissue inflammation.
   Google Scholar
• Hellmann J, Tang Y, Kosuri M, Bhatnagar A, Spite M. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese‑diabetic mice. FASEB J. 25, 2399–2407 (2011). Original study that documented that RvD1 enhances insulin sensitivity.
   Google Scholar
• Clària J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol. 189, 2597–2605 (2012). Original study that showed that Rvs attenuate adipose tissue inflammation.
   Google Scholar
• Serhan CN, Yang R, Martinod K et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15–23 (2009).
   Google Scholar
• Serhan CN, Dalli J, Karamnov S et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26, 1755–1765 (2012).
   Google Scholar
• Serhan CN, Gotlinger K, Hong S et al. Antiinflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxycontaining docosatrienes. J. Immunol. 176, 1848–1859 (2006).
   Google Scholar
• Bellenger J, Bellenger S, Bataille A et al. High pancreatic n‑3 fatty acids prevent STZ‑induced diabetes in fat‑1 mice: inflammatory pathway inhibition. Diabetes 60, 1090–1099 (2011). Original study that documented that n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid prevent streptozotocin-induced DM by producing their antiinflammatory products such as Rvs and paradoxically enhancing the formation of LXA4 depsite a deficiency of its precursor A4. This indicated that LXA4 has antidiabetic action.
   Google Scholar
• Das UN. Insulin resistance and hyperinsulinemia: are they secondary to an alteration in the metabolism of essential fatty acids? Med. Sci. Res. 22, 243–245 (1994). One of the first papers to suggest that PUFAs may have a role in the regulation of insulin resistance.
   Google Scholar
• Das UN. GLUT‑4, tumor necrosis factor, essential fatty acids and daf‑genes and their role in insulin resistance and non‑insulin dependent diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 60, 13–20 (1999).
   Google Scholar
• Das UN. A defect in the activity of D6 and D5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot. Essent. Fatty Acids 72, 343–350 (2005).
   Google Scholar
• Das UN. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids 67, 1–12 (2002).
   Google Scholar
• Brüning JC, Michael MD, Winnay JN et al. A muscle‑specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2, 559–569 (1998).
   Google Scholar
• Moller DE, Chang PY, Yaspelkis BB 3rd, Flier JS, Wallberg‑Henriksson H, Ivy JL. Transgenic mice with muscle‑specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia. Endocrinology 137, 2397–2405 (1996).
   Google Scholar
• Kim JK, Michael MD, Previs SF et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Invest. 105, 1791–1797 (2000).
   Google Scholar
• Zisman A, Peroni OD, Abel D et al. Targeted disruption of the glucose transported 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6, 924–928 (2000).
   Google Scholar
• Kim JK, Zisman A, Fillmore JJ et al. Glucose toxicity and the development of diabetes in mice with muscle‑specific inactivation of GLUT4. J. Clin. Invest. 108, 153–160 (2001).
   Google Scholar
• Kim YB, Peroni OD, Aschenbach WG et al. Muscle‑specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism. Mol. Cell Biol. 25, 9713–9723 (2005).
   Google Scholar
• Stenbit AE, Tsao TS, Li J et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 3, 1096–1101 (1997).
   Google Scholar
• Katz EB, Stenbit AE, Hatton K, DePinhot R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377, 151–155 (1995).
   Google Scholar
• Dohm GL, Elton CW, Friedman JE et al. Decreased expression of glucose transporter in muscle from insulin‑resistant patients. Am. J. Physiol. 260(3 Pt 1), e459–e463 (1991).
   Google Scholar
• Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT‑4 glucose transporters in adipocytes. Am. J. Physiol. 264(2 Pt 1), e197–e202 (1993).
   Google Scholar
• Pedersen O, Kahn CR, Flier JS, Kahn BB. High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats. Endocrinology 129, 771–777 (1991). Original study that showed that a high-fat diet causes insulin resistance by decreasing the expression of glucose transporter 4. This is interesting in light of the fact that glucose transporter 4 knockout does not produce diabetes – see [89].
   Google Scholar
• Friedman JE, Ishizuka T, Liu S et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am. J. Physiol. 273(5 Pt 1), e1014–e1023 (1997).
   Google Scholar
• Das UN, Vijay Kumar K, Krishna Mohan I. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J. Nutr. Med. 4, 149–155 (1994). One of the first manuscripts to show that patients with Type 2 DM have low plasma levels of PUFAs such as arachidonic acid.
   Google Scholar
• Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot. Essent. Fatty Acids 52, 387–391 (1995).
   Google Scholar
• Krishna Mohan I, Das UN. Prevention of chemically‑induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition 17, 126–151 (2001). One of the first papers to show that oils rich in PUFAs can indeed prevent alloxan-induced Type 1 DM.
   Google Scholar
• Suresh Y, Das UN. Long‑chain polyunsaturated fatty acids and chemicallyinduced diabetes mellitus: effect of w‑6 fatty acids. Nutrition 19, 93–114 (2003). One of the first papers to show that n-6 PUFAs, especially arachidonic acid, can indeed prevent alloxan-induced Type 1 DM in experimental animal models.
   Google Scholar
• Suresh Y, Das UN. Long‑chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of w‑3 fatty acids. Nutrition 19, 213–228 (2003). One of the first papers to show that n-3 PUFAs can prevent alloxan-induced Type 1 DM in experimental animal models.
   Google Scholar
• Suresh Y and Das UN. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan‑induced diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 74, 199–213 (2006).
   Google Scholar
• Sailaja MM, Das UN. Effect of prostaglandins against alloxan‑induced diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 74, 39–60 (2006).
   Google Scholar
• González‑Périz A, Horrillo R, Ferré N et al. Obesity induced insulin resistance and hepatic steatosis are alleviated by omega‑3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946–1957 (2009).
   Google Scholar
• Borgeson E, Godson C. Resolution of inflammation: therapeutic potential of proresolving lipids in Type 2 diabetes mellitus and associated renal complications. Front. Immunol. 3, 318 (2012).
   Google Scholar
• Bousserouel S, Raymondjean M, Brouillet A, Bèrèziat G, Andrèani M. Modulation of cyclin D1 and early growth response factor‑1 gene expression in interleukin‑1b‑treated rat smooth muscle cells by n‑6 and n‑3 polyunsaturated fatty acids. Eur. J Biochem. 271, 4462–4473 (2004).
   Google Scholar
• Watson RT, Shigematsu S, Chiang SH et al. Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and GLUT4 translocation. J. Cell Biol. 154, 829–840 (2001).
   Google Scholar
• Pérez‑Matute P, Pérez‑Echarri N, Martínez JA, Marti A, Moreno‑Aliaga MJ. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high‑fat‑fed rats: role of apoptosis, adiponectin and tumour necrosis factor‑alpha. Br. J. Nutr. 97, 389–398 (2007).
   Google Scholar
• Todoric J, Löffler M, Huber J et al. Adipose tissue inflammation induced by high‑fat diet in obese diabetic mice is prevented by n‑3 polyunsaturated fatty acids. Diabetologia 49, 2109–2119 (2006).
   Google Scholar
• Duque‑Guimarães DE, de Castro J, Martinez‑Botas J et al. Early and prolonged intake of partially hydrogenated fat alters the expression of genes in rat adipose tissue. Nutrition 25, 782–789 (2009).
   Google Scholar
• Taouis M, Dagou C, Ster C, Durand G, Pinault M, Delarue J. N‑3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am. J. Physiol. Endocrinol. Metab. 282, e664–e671 (2002).
   Google Scholar
• Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP. Insulin and insulin‑like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 136, 5718–5724 (1995).
   Google Scholar
• Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am. J. Surg. 184, S9–S16 (2002).
   Google Scholar
• Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult‑onset diabetes mellitus. Ann. Surg. 222, 339–350 (1995).
   Google Scholar
• Das UN. Metabolic syndrome is a low grade systemic inflammatory condition. Expert Rev. Endocrinol. Metab. 4, 577–592 (2010).
   Google Scholar
• Meguid MM, Ramos EJB, Suzuki S et al. A surgical model of human Roux‑en‑Y gastric bypass. J. Gastrointest. Surg. 8, 621–630 (2004).
   Google Scholar
• Xu Y, Ramos EJ, Middleton F et al. Gene expression profiles post Roux‑en‑Y gastric bypass. Surgery 136, 246–252 (2004).
   Google Scholar
• Romanova I, Ramos EJ, Xu Y et al. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J. Am. Coll. Surg. 199, 887–895 (2004).
   Google Scholar
• Vendrell J, Broch M, Vilarrasa N et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12, 962–971 (2004).
   Google Scholar
• Das UN. Vagus nerve stimulation in the prevention and management of insulin resistance and metabolic syndrome. Med. Hypotheses 76, 429–433 (2011).
   Google Scholar
• Li J, Zhang H, Wu F et al. Insulin inhibits tumor necrosis factor‑alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit. Care Med. 36, 1551–1558 (2008).
   Google Scholar
• Das UN. Possible beneficial action(s) of glucose‑insulin‑potassium regimen in acute myocardial infarction and inflammatory conditions: a hypothesis. Diabetologia 43, 1081–1082 (2000).
   Google Scholar
• Das UN. Is insulin an anti‑inflammatory molecule? Nutrition 17, 409–413 (2001).
   Google Scholar
• Das UN. Essential fatty acids: Biochemistry, physiology, and pathology. Biotech. J. 1, 420–439 (2006).
   Google Scholar
• Das UN. Essential fatty acids – a review. Current Pharmaceut. Biotech. 7, 467–482 (2006).
   Google Scholar
• Das UN. Biological significance of essential fatty acids. J. Assoc. Physicians India 54, 309–319 (2006).
   Google Scholar
• Das UN. Molecular Basis of Health and Disease. Springer, NY, USA (2011). Comprehensive book that discusses the role of LXs, Rvs, protectins and nitrolipids in the pathobiology of several adult diseases.
   Google Scholar
• De Souza CT, Araujo EP, Bordin S et al. Consumption of a fat‑rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199 (2005).
   Google Scholar
• Posey KA, Clegg DJ, Printz RL et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high‑fat diet. Am. J. Physiol. Endocrinol. Metab. 296, e1003–e1012 (2009).
   Google Scholar
• Moraes JC, Coope A, Morari J et al. High‑fat diet induces apoptosis of hypothalamic neurons. PLoS ONE 4, e5045 (2009).
   Google Scholar
• Romanatto T, Roman EA, Arruda AP et al. Deletion of tumor necrosis factor‑alpha receptor 1 (TNFR1) protects against dietinduced obesity by means of increased thermogenesis. J. Biol. Chem. 284, 36213–36222 (2009).
   Google Scholar
• Oh‑I S, Thaler JP, Ogimoto K, Wisse BE, Morton GJ, Schwartz MW. Central administration of interleukin‑4 exacerbates hypothalamic inflammation and weight gain during high‑fat feeding. Am. J. Physiol.Endocrinol. Metab. 299, e47–e53 (2010).
   Google Scholar
• Calegari VC, Torsoni AS, Vanzela EC et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J. Biol. Chem. 286, 12870–12880 (2011). Interesting study that showed that hypothalamic inflammation dysregulates pancreatic β-cell function.
   Google Scholar
• Thaler JP, Yi CX, Schur EA et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012).
   Google Scholar
• DeGeorge JJ, Ousley AH, McCarthy KD, Lapetina EG, Morell P. Acetylcholine stimulates selective liberation and reesterification of arachidonate and accumulation of inositol phosphates and glycerophosphoinositol in C62B glioma cells. J. Biol. Chem. 262, 8077–8083 (1987).
   Google Scholar
• Pinchasi I, Burstein M, Michaelson DM. Metabolism of arachidonic acid and prostaglandins in the Torpedo electric organ: modulation by the presynaptic muscarinic acetylcholine receptor. Neuroscience 13, 1359–1364 (1984).
   Google Scholar
• Reichman M, Nen W, Hokin LE. Acetylcholine releases prostaglandins from brain slices incubated in vitro. J. Neurochem. 49, 1216–1221 (1987).
   Google Scholar
• Shimamoto C, Nakanishi Y, Katsu K et al. Prostaglandin E2 release in gastric antral mucosa of guinea‑pigs: basal PGE2 release by cyclo‑oxygenase 2 and ACh‑stimulated PGE2 release by cyclooxygenase 1. Exp. Physiol. 91, 1015–1024 (2006).
   Google Scholar
• Das UN. Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia. Progress Neuropsychopharmacol. Biol. Psychiatry 42, 122–134 (2012).
   Google Scholar
• Das UN. Long‑chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor‑β to prevent human essential hypertension. Eur. J. Clin. Nutr. 58, 195–203 (2004).
   Google Scholar
• Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271–275 (2002). Interesting study that showed that hypothalamic infusion of oleic acid reverses DM.
   Google Scholar
• Cintra DE, Ropellez ER, Moraes JC et al. Unsaturated fatty acids revert diet‑induced hypothalamic inflammation in obesity. PLoS ONE 7, e30571 (2012). Original study that showed that hypothalamic inflammation can be reversed by supplementation of PUFAs.
   Google Scholar
• Khoo NK, Freeman BA. Electrophilic nitrofatty acids: anti‑inflammatory mediators in the vascular compartment. Curr. Opin. Pharmacol. 10, 179–184 (2010).
   Google Scholar
• Das UN. Autism as a disorder of deficiency of brain‑derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition (2013) (In Press).
   Google Scholar
• Das UN. Is lipoxins A4 a better alternative to anti‑VEGF and anti‑TNF‑alpha antibody to prevent and treat age‑related macular degeneration, diabetic macular edema and retinopathy? Med. Sci. Monit. 18, LE1–LE2 (2011).
   Google Scholar
• Das UN. Lipoxins, resolvins and protectins in the prevention and treatment of diabetic macular edema and retinopathy. Nutrition 29, 1–7 (2013).
   Google Scholar
• Suryaprabha P, Das UN et al. Free radicals, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot. Essent. Fatty Acids 41, 27–33 (1990).
   Google Scholar
• Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic. Res. Commun. 19, 59–66 (1993).
   Google Scholar
• Das UN. Can perinatal supplementation of long chain polyunsaturated fatty acids prevent hypertension in adult life? Hypertension 38, e6–e8 (2001).
   Google Scholar
• Das UN. Interaction(s) of polyunsaturated fatty acids with dietary protein and its relationship to the pathogenesis of hypertension. Am. J. Hypertension 23, 111–112 (2010).
   Google Scholar
• Das UN. Essential fatty acids and their metabolites in the context of hypertension. Hypertension Res. 33, 782–785 (2010).
   Google Scholar
• Das UN. Pre(peri)‑natal w‑3 PUFA deficiency‑induced hypertension and its broader implications. Hypertension Res. 35, 375–379 (2012).
   Google Scholar
• Weisinger HS, Armitage JA, Sinclair AJ, Vingrys AJ, Burns PL, Weisinger RS. Perinatal omega‑3 fatty acid deficiency affects blood pressure later in life. Nat. Med. 7, 258–259 (2001). One of the first reports to show that perinatal deficiency of n-3 PUFAs may produce hypertension in the adult.
   Google Scholar
• Armitage JA, Pearce AD, Sinclair AJ, Vingrys AJ, Weisinger RS, Weisinger HS. Increased blood pressure later in life may be associated with perinatal n‑3 fatty acid deficiency. Lipids 38, 459–464 (2003).
   Google Scholar
• Li D, Weisinger HS, Weisinger RS et al. Omega 6 to omega 3 fatty acid imbalance early in life leads to persistent reductions in DHA levels in glycerophospholipids in rat hypothalamus even after longterm omega 3 fatty acid repletion. Prostaglandins Leukot. Essent. Fatty Acids 74, 391–399 (2006).
   Google Scholar
• Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595–3606 (2008).
   Google Scholar
• Macdonald LJ, Boddy SC, Denison FC, Sales KJ, Jabbour HN. A role for lipoxin A4 as an antiinflammatory mediator in the human endometrium. Reproduction 142, 345–352 (2011).
   Google Scholar
• Ni J, Huang YJ, Wu M et al. Effect of lipoxins on proliferation and secretion of peritoneal macrophages from patients with preeclampsia in vitro. Zhonghua Fu Chan Ke Za Zhi 43, 325–328 (2008).
   Google Scholar
• Bimbaum Y, Ye Y, Lin Y et al. Augmentation of myocardial production of 15‑epi‑lipoxin‑A4 by pioglitazone and atorvastatin in the rat. Circulation 114, 929–935 (2006).
   Google Scholar
• Levy BD. Myocardial 15‑Epi‑lipoxin A4 generation provides a new mechanism for the immunomodulatory effects of statins and thiazolidinediones. Circulation 114, 873–875 (2006).
   Google Scholar
• Planagumà A, Pfeffer MA, Rubin G et al. Lovastatin decreases acute mucosal inflammation via 15‑epi‑lipoxin A4. Mucosal Immunol. 3, 270–279 (2010).
   Google Scholar
• Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ. Res. 107, 1170–1184 (2010).
   Google Scholar
• Zhou G, Ge S, Liu D et al. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5‑lipoxygenase pathway. Cardiology 115, 221–228 (2010).
   Google Scholar
• Das UN. Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits – is there a common link? Nutrition 18, 178–188 (2002).
   Google Scholar
• Das UN. Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot. Essent. Fatty Acids 65, 37–40 (2001).
   Google Scholar
• Bonventre JV. Phospholipase A2 and signal transduction. J. Am. Soc. Nephrol. 3, 128–150 (1992).
   Google Scholar
• Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612–619 (2001).
   Google Scholar
• Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte‑derived macrophages. J. Immunol. 164, 1663–1667 (2000).
   Google Scholar
• Gilroy DW Colville‑Nash PR, Willis D, Chivers J, Paul‑Clark MJ, Willoughby DA. Inducible cyclooxygenase may have antiinflammatory properties. Nat. Med. 5, 698–701 (1999).
   Google Scholar
• Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, Croxtall JD. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 18, 489–498 (2004).
   Google Scholar
• Cominelli F, Nast CC, Llerena R, Dinarello CA, Zipser RD. Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins. J. Clin. Invest. 85, 582–586 (1990).
   Google Scholar
• Schwab JH, Anderle SK, Brown RR, Dalldorf FG, Thompson RC. Pro‑ and antiinflammatory roles of interleukin‑1 in recurrence of bacterial cell wall‑induced arthritis in rats. Infect. Immun. 59, 4436–4442 (1991). Original study that showed that Rvs have anti-inflammatory actions.
   Google Scholar
• Serhan CN, Hong S, Gronert K et al. Resolvins: a family of bioactive products of omega‑3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025–1037 (2002).
   Google Scholar
• Croxtall JD, Choudhury Q, Tokumoto H, Flower RJ. Lipocortin‑1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein‑dependent activation of cPLA2 activity. Biochem. Pharmacol. 50, 465–474 (1995).
   Google Scholar
• Wang SB, Hu KM, Seamon KJ, Mani V, Chen Y, Gronert K. Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J. 26, 1506–1516 (2012).
   Google Scholar